Basel, 23.06.2020 – BVL-GSK098 IS BEING DEVELOPED FOR THE TREATMENT OF MULTI-DRUG RESISTANT TUBERCULOSIS INFECTIONS

30.07.2020 – Improving the success of R&D efforts in the fight against AMR is one of the long-term goals of COMBINE. To this end, the consortium calls upon the AMR community to share data from studies of prevention or treatment of bacterial infections.